Nosocomial Pneumonia: Strategies for Management

Nosocomial pneumonia  is the second most frequent hospital–acquired infection and the most common acquired infection in the intensive care unit. It can be caused by several different pathogens, and determining the most appropriate therapy is further complicated by a number of differential diagnoses – other disorders that mimic this disease, which can only be confirmed or excluded following laboratory tests. It therefore presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of a group of patients whose ability to combat infection is frequently already compromised. 
In this new work, leading international authorities present an update on current best practice for the diagnosis, treatment, and prevention of nosocomial pneumonia. The first section of the book describes the environmental factors that lead to infection, and the clinical approaches appropriate to patients at risk. There then follows a series of chapters dedicated to each of the principal pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii and the specific strategies by which infections with these organisms may be combated. Finally, the authors address the problems associated with particular risk groups, including the immuno–compromised, trauma patients, and the presence of concomitant morbidities such as Acute Respiratory Distress Syndrome.
This volume will be welcomed by pulmonologists, intensivists, and by all clinicians involved in managing pulmonary infections acquired in the hospital sett

Spis treści:
Preface.
List of Contributors.
Abbreviations.
1. Health Care Associated–Pneumonia: Epidemiology, Microbiology and Clinical Outcomes (Dr. Marcos I. Restrepo and Dr. Antonio Anzuelo, San Antonio, Texas. US).
2. Prevention of Hospital–Acquired Pneumonia (Dr. Rafael Sierra and
60;Antonio Gordillo, Cádiz, Spain).
3. Role of the microbiology laboratory in the diagnosis of ventilator–associated pneumonia (Dr. Emilio Bouza, Dra. Almudena Burillo, Dra. Patricia Muñoz, Madrid, Spain).
4. Pathophysiology of Pneumonia (Dra Amalia Alcón, Dr. Mauricio Valencia, Dr. Antoni Torres, Barcelona, Spain).
5. Clinical approach to the patient with HAP (Dr. Jordi Rello, Tarragona, Spain & Dr. Miguel Gallego, Sabadell, Spain).
6. Pneumonia due to Pseudomonas aeruginosa (Dr. Jordi Vallés and Dra. Dolors Marisca, Sabadell. Spain).
7. Hospital acquired–pneumonia caused by Staphylococcus aureus (Dra. Despoina Koulenti, Athens, Greece; Dr. Kemal Agbaht, Ankara, Turkey).
8. Nosocomial pneumonia by Acinetobacter baumannii (Dr. José Garnacho–Montero and Da. Eugenia Pachón, Dr. J.M. Cisneros, Sevilla, Spain).
9. Fungal pneumonia (Dr. George Dimopoulos, Dr. E. Papadomichelakis, Dr. P. Kopteridis, Athens, Greece).
10. General pharmacologic considerations and dose adjustment in antibiotic therapy for HAP (Dr. Pierluigi Viale and Dr. Federico Pea, Udine, Italy).
11. Minimally Invasive Diagnostic Strategy in Immunocompromized Patients with Pulmonary Infiltrates (Dra. Sandra. De Miranda and Dra. Élie Azoulay, Paris, France).
12. Pneumonia in trauma patients (Dra. Helene A. Haeberle and Dr. Wolfgang A. Krueger, Tubingen. Germany).
13. Acute Respiratory Distress Syndrome and pneumonia (Dr. Jean Chastre, Dr. Charles–Edouard Luyt, Dr. Jean Louis Trouillet, Dr. Alain Combes, Paris, France).
14. Assessment of patients with poor resolution of Hospital Acquired Pneumonia (Dr. Richard G. Wunderink, Dr. Keenan A. Hawkins, Chicago, USA).
15. Approach to Patients with recurrent VAP (Dr. Grant W. Waterer, Perth, Australia; Dr. Diego López. Madrid. Spain).
16. Costs for Hospital–Acquired Pneumonia & Ventila tor–Associated Pneumonia (Dr. Andrew F. Shorr and Dr. William L. Jackson, Washington, USA).
Index.

Nota biograficzna:
Dr. Jordi Rello, MD. Chief, Critical Care Department, Joan XXIII University Hospital, University Rovira i Virgili, Institut Pere Virgili, Tarragona, SPAIN.

Okładka tylna:
Nosocomial pneumonia  is the second most frequent hospital–acquired infection and the most common acquired infection in the intensive care unit. It can be caused by several different pathogens, and determining the most appropriate therapy is further complicated by a number of differential diagnoses – other disorders that mimic this disease, which can only be confirmed or excluded following laboratory tests. It therefore presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of a group of patients whose ability to combat infection is frequently already compromised. 
In this new work, leading international authorities present an update on current best practice for the diagnosis, treatment, and prevention of nosocomial pneumonia. The first section of the book describes the environmental factors that lead to infection, and the clinical approaches appropriate to patients at risk. There then follows a series of chapters dedicated to each of the principal pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus, Acinetobacter baumannii and the specific strategies by which infections with these organisms may be combated. Finally, the authors address the problems associated with particular risk groups, including the immuno–compromised, trauma patients, and the presence of concomitant morbidities such as Acute Respiratory Distress Syndrome.
This volume will be welcomed by pulmonologists, intensivists, and by all clinicians involved in managing pulmonary infections acquired in the hospi tal sett